Search Result "steatohepatitic"
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 38 Year: 2018 Page: 4574-4586
Author(s): Margarita Papatheodoridi,Evangelos Cholongitas
Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 13 Year: 2018 Page: 1480-1500
Author(s): Sho-ichi Yamagishi,Takanori Matsui
Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 1 Year: 2014 Page: 2377-2386
Author(s): Sho-ichi Yamagishi, Takanori Matsui
Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 246-253
Author(s): Vasilios G. Athyros,Chrysa Boutari,Konstantinos Stavropoulos,Panagiotis Anagnostis,Konstantinos P. Imprialos,Michael Doumas,Asterios Karagiannis
Effects of Liver Diseases on Drug-metabolizing Enzymes: Implications for Drug Fate Alterations and Nano-therapeutic Openings
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 22 Year: 2014 Page: 2522-2541
Author(s): L. Lu,J. Shi,Q. Li,X. Peng,L. Dong,Y. Li,P. Dai,Y. Wang,E. Guo,F. Zhou,Z. Liu
Cytochrome P450 and Steatosis
Journal: Current Drug Metabolism
Volume: 10 Issue: 7 Year: 2009 Page: 692-699
Author(s): Maria Jose Gomez-Lechon, Ramiro Jover, Maria Teresa Donato
Histopathological Changes of NAFLD
Ebook: Nonalcoholic Fatty Liver Disease (NAFLD)
Volume: 1 Year: 2017
Author(s): Peter Nagy
Doi: 10.2174/9781681084657117010007
Hepatocellular Carcinoma: Diagnosis, Molecular Pathogenesis, Biomarkers, and Conventional Therapy
Ebook: Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039740122010003